ACCELERATING RESEARCH, DELIVERING CURES Trademark

Trademark Overview

On Tuesday, August 16, 2022, a trademark application was filed for ACCELERATING RESEARCH, DELIVERING CURES with the United States Patent and Trademark Office. The USPTO has given the ACCELERATING RESEARCH, DELIVERING CURES trademark a serial number of 97549939. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, October 28, 2024. This trademark is owned by Globyz Pharma LLC. The ACCELERATING RESEARCH, DELIVERING CURES trademark is filed in the Advertising, Business and Retail Services category with the following description:

Sourcing pharmaceuticals, namely, procurement, namely, purchasing pharmaceutical preparations for clinical trial supply for others

General Information

Serial Number97549939
Word MarkACCELERATING RESEARCH, DELIVERING CURES
Filing DateTuesday, August 16, 2022
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesSourcing pharmaceuticals, namely, procurement, namely, purchasing pharmaceutical preparations for clinical trial supply for others

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, November 30, 2022
Primary Code035
First Use Anywhere DateWednesday, January 5, 2022
First Use In Commerce DateWednesday, January 5, 2022

Trademark Owner History

Party NameGlobyz Pharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBoothwyn, PA 19061

Trademark Events

Event DateEvent Description
Friday, August 19, 2022NEW APPLICATION ENTERED
Tuesday, September 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 27, 2022ASSIGNED TO EXAMINER
Tuesday, November 1, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 1, 2022NON-FINAL ACTION E-MAILED
Tuesday, November 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 3, 2022NON-FINAL ACTION WRITTEN
Thursday, November 3, 2022NON-FINAL ACTION E-MAILED
Thursday, November 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 12, 2022SUSPENSION LETTER WRITTEN
Monday, December 12, 2022LETTER OF SUSPENSION E-MAILED
Monday, December 12, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, June 12, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, December 11, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 29, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Related Keywords

cures delivering research accelerating namely clinical trial supply preparations others pharmaceutical pharmaceuticals procurement purchasing